Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-25 @ 4:11 PM
Study NCT ID:
NCT00302757
Status:
COMPLETED
Last Update Posted:
2014-05-29
First Post:
2006-03-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
Sponsor:
University Hospital Tuebingen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-10
First Submit QC Date:
None
Study First Post Date:
2006-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-28
Last Update Post Date:
2014-05-29
Last Update Post Date Type:
ESTIMATED